Alogliptin, the Latest DPP-4 Inhibitor

I have to be disappointed in my
research sources. My (what I thought was my best source of oral
medications) resources have turned out to be a big disappointment to
me. I had been relying on the National Diabetes Information Clearinghouse (NDIC), which is part of the National Institute of
Diabetes and Digestive and Kidney Diseases (NIDDK), National
Institutes of Health (NIH), and a division